Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 31, 2012

View Archived Issues

Isis Innovation presents new dsNA molecules for Parkinson's disease

Del Mar Pharmaceuticals expands collaboration with Guangxi Wuzhou Pharmaceutical

Global phase III trial of ART-123 commences

AstraZeneca begins new global study of Faslodex

Astex Pharmaceuticals, CRT and Newcastle University form drug discovery alliance

Chinese researchers disclose novel Lp-PLA2 inhibitors

Astellas Pharma prepares new PDE10A inhibitors

New modulators of the expression of aquaporin-3 patented by Lipotec

Dainippon Sumitomo Pharma synthesizes novel nACh alpha7 receptor modulators

Researchers at Pathway Therapeutics disclose new PI3K inhibitors

Complix receives government grant for Alphabodies development

Takeda submits Japanese NDA for cetilistat

Astellas Pharma launches Quattrovac vaccine in Japan

Combination of BKM-120 and irinotecan evaluated in phase I trial

TransTech Pharma's TTP-488 slows cognitive decline in Alzheimer's disease

Preliminary phase II data presented for lubrinectedin in ovarian cancer

Cytokinetics begins phase IIb BENEFIT-ALS trial

Amgen offers overview of third quarter 2012 results

Novartis reports third quarter results for 2012

European Commission approves Cialis in new indication

FDA accepts two Latuda supplemental NDAs for review

Oral salmon calcitonin shows potential as antidiabetic therapy in vivo

GSK begins phase III program for mepolizumab in severe refractory asthma

Phase I IPH-2102 trial begins patient recruitment

NCI presents phase II data for a cervical cancer vaccine

Semaphorin-3A demonstrates osteoprotective qualities and therapeutic potential

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...